- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
2
0 new
High return on equity, past performance and sound balance sheet.
2 companies
Consun Pharmaceutical Group
Market Cap: HK$11.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$13.68
7D
9.6%
1Y
148.7%
Uni-Bio Science Group
Market Cap: HK$746.4m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.13
7D
0%
1Y
140.4%